Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Overstappen van tetrabenazine naar deutetrabenazine is veilig
jul 2017 | Neuro-musculair